Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Erythropoiesis01:14

Erythropoiesis

4.7K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

489
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
489
Hematopoiesis01:21

Hematopoiesis

5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV).

Infectious agents and cancer·2026
Same author

Ionic liquid assisted gel casting of cellulose BSG protein mixtures for packaging films.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2026
Same author

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Uveal Melanoma: Biology, Prognostication, and Emerging Therapies to Outsmart an Immune-Cold Melanoma.

Cancers·2026
Same author

Directed differentiation of functional corticospinal-like neurons from endogenous SOX6+/NG2+ cortical progenitors.

eLife·2026
Same author

Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma.

Cancer treatment and research communications·2026
Same journal

Association of glucagon-like peptide 1 receptor and the aggressiveness of extrahepatic cholangiocarcinoma.

Cancer treatment and research communications·2026
Same journal

The microbiome-epigenome axis: Regulation of host genome function across development and disease.

Cancer treatment and research communications·2026
Same journal

A comparative analysis of cytotoxic effects: Lactobacillus reuteri Extract vs. Newcastle Disease Virus in human colorectal cancer (HT-29 cell line).

Cancer treatment and research communications·2026
Same journal

The influence of CD117, CD133, CD24, CD44, and ALDH expression on progression-free survival in advanced-stage epithelial ovarian cancer patients.

Cancer treatment and research communications·2026
Same journal

Role of microRNA-451a in molecular pathology of cancer.

Cancer treatment and research communications·2026
Same journal

Imaging modality, incidental detection, and age-stage distribution in surgically treated clear cell renal cell carcinoma.

Cancer treatment and research communications·2026
See all related articles

Related Experiment Video

Updated: Sep 4, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

3.7K

Eponyms in Malignant Hematology.

Danielle Brazel1, Priyanka Kumar1, David J Benjamin2

  • 1Department of Medicine, University of California, Irvine Medical Center, Orange, California, United States.

Cancer Treatment and Research Communications
|July 14, 2022
PubMed
Summary
This summary is machine-generated.

This review examines medical eponyms in malignant hematology, detailing disease pathophysiology, epidemiology, and the history of honorees. It addresses ethical concerns surrounding these disease names.

Keywords:
Auer rodsBence Jones proteinsBurkitt LymphomaHodgkin lymphomaMalignant hematology eponymsReed-Sternberg cells

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K

Related Experiment Videos

Last Updated: Sep 4, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

3.7K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K

Area of Science:

  • Medical Humanities
  • Hematology
  • Medical Ethics

Background:

  • Medical eponyms traditionally honor individuals for disease discoveries.
  • Concerns arise regarding the backgrounds of individuals honored by eponyms.
  • Previous work reviewed oncology eponyms; this study focuses on hematology.

Purpose of the Study:

  • To review commonly used eponyms in malignant hematology.
  • To highlight the individuals after whom these hematologic conditions are named.
  • To discuss the historical context of eponyms in hematology.

Main Methods:

  • Literature review of malignant hematology eponyms.
  • Analysis of disease pathophysiology and epidemiology.
  • Historical research into the individuals honored by eponyms.

Main Results:

  • Identified and analyzed key eponyms in malignant hematology.
  • Detailed the scientific contributions and historical backgrounds of associated individuals.
  • Provided context on the ongoing debate surrounding medical eponyms.

Conclusions:

  • Understanding the history behind malignant hematology eponyms is crucial.
  • This review facilitates informed discussion on the use of eponyms in medicine.
  • Acknowledges the ethical considerations in medical nomenclature.